Found: 14
Select item for more details and to access through your institution.
Population Pharmacokinetic Analysis of Bintrafusp Alfa in Different Cancer Types.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Variability in the population pharmacokinetics of pyrazinamide in South African tuberculosis patients.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 9, p. 727, doi. 10.1007/s00228-006-0141-z
- By:
- Publication type:
- Article
The guard changes.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2020, v. 47, n. 1, p. 3, doi. 10.1007/s10928-020-09672-6
- By:
- Publication type:
- Article
Data standards for model-informed drug development: an ISoP initiative.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2018, v. 45, n. 5, p. 659, doi. 10.1007/s10928-018-9595-8
- By:
- Publication type:
- Article
Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 72, n. 1, p. 51, doi. 10.1111/j.1365-2125.2011.03940.x
- By:
- Publication type:
- Article
Changing Body Weight–Based Dosing to a Flat Dose for Avelumab in Metastatic Merkel Cell and Advanced Urothelial Carcinoma.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 3, p. 588, doi. 10.1002/cpt.1645
- By:
- Publication type:
- Article
Characterization of exposure–response relationships of ipatasertib in patients with metastatic castration-resistant prostate cancer in the IPATential150 study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2022, v. 90, n. 6, p. 511, doi. 10.1007/s00280-022-04488-2
- By:
- Publication type:
- Article
Model-informed approach for risk management of bleeding toxicities for bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Covariate modeling in pharmacometrics: General points for consideration.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 5, p. 710, doi. 10.1002/psp4.13115
- By:
- Publication type:
- Article
R and nlmixr as a gateway between statistics and pharmacometrics.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 4, p. 283, doi. 10.1002/psp4.12618
- By:
- Publication type:
- Article
Performance of the SAEM and FOCEI Algorithms in the Open‐Source, Nonlinear Mixed Effect Modeling Tool nlmixr.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2019, v. 8, n. 12, p. 923, doi. 10.1002/psp4.12471
- By:
- Publication type:
- Article
Nonlinear Mixed‐Effects Model Development and Simulation Using nlmixr and Related R Open‐Source Packages.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2019, v. 8, n. 9, p. 621, doi. 10.1002/psp4.12445
- By:
- Publication type:
- Article
Time-Varying Clearance and Impact of Disease State on the Pharmacokinetics of Avelumab in Merkel Cell Carcinoma and Urothelial Carcinoma.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2019, v. 8, n. 6, p. 415, doi. 10.1002/psp4.12406
- By:
- Publication type:
- Article
A drug and disease model for lixisenatide, a GLP-1 receptor agonist in type 2 diabetes.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 3, p. 267, doi. 10.1002/jcph.192
- By:
- Publication type:
- Article